UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation Journal article
Li, Lin, Xu, Nan, He, Yulin, Tang, Mingsui, Yang, Binrui, Du, Jun, Chen, Liang, Mao, Xiaowen, Song, Bing, Hua, Zhou, Tang, Benqin, Lee, Simon Ming yuen. Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation[J]. Neurotherapeutics, 2024, e00479.
Authors:  Li, Lin;  Xu, Nan;  He, Yulin;  Tang, Mingsui;  Yang, Binrui; et al.
Favorite | TC[Scopus]:0  IF:5.6/6.9 | Submit date:2024/12/26
Neuroinflammation  19,20-dehydroervatamine  Trem2  Nf-κb  Nlrp3  
Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway. Journal article
Tang, Xiaowen, Liao, Qi, Li, Qinqin, Jiang, Linshan, Li, Wei, Xu, Jie, Xiong, Aizhen, Wang, Rufeng, Zhao, Jing, Wang, Zhengtao, Ding, Lili, Yang, Li. Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway.[J]. European Journal of Pharmacology, 2024, 965, 176196.
Authors:  Tang, Xiaowen;  Liao, Qi;  Li, Qinqin;  Jiang, Linshan;  Li, Wei; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:4.2/4.3 | Submit date:2024/02/22
Lusianthridin  Mafld  Fxr  Srebp1c